Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines

Pediatric Infectious Disease Journal

Volumn 15, Issue 5, 1996, Pages 425-430

  O'Brien, K L ^b,f   Steinhoff, M C ^a   Edwards, K ^c   Keyserling, H ^d   Thoms, M L ^a   Madore, D ^e  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Lederle Praxis Biologices Inc   (United States)

^f NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

bacterial antibodies; conjugate vaccine; IgG; IgG subclasses; immunology; Pneumococcal vaccine

Indexed keywords

IMMUNOGLOBULIN G; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CHILD; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOMODULATION; KINETICS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROTYPE;

BACTERIAL PROTEINS; CHILD, PRESCHOOL; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; INFANT; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, SYNTHETIC;

EID: 0029972485     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199605000-00009     Document Type: Article

References (22)

1. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV and the Bacterial Meningitis Study Group. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. J Infect Dis 1990;162:1316-23.
2. Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978 to 1994: implications for development of a conjugate vaccine. J Infect Dis 1995;171:885-9.
3. Leinonen M, Säkkinen A, Kalliokoski R, Luotonen J, Timonen M, Mäkelä PH. Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Pediatr Infect Dis 1986;5:39-44.
4. Koskela M, Leinonen M, Häivä V, Timonen M, Mäkelä PH. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. Pediatr Infect Dis 1986;5: 45-50.
5. Baltimore RS. New challenges in the development of a conjugate pneumococcal vaccine. JAMA 1992;268:3366-7.
6. Stein KE. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect Dis 1992; 165(Suppl. 1)849-52.
7. Steinhoff MC, Edwards K, Keyserling H, et al. A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: effect of polysaccharide size and linkage characteristics. Pediatr Infect Dis J 1994;13:368-72.
8. Kennedy D, Derousse C, Anderson E. Immunologic response of 12-18 month old children to licensed pneumococcal polysaccharide vaccine (PS) primed with Streptococcus pneumoniae 19F conjugate vaccine (CV) [Abstract G88]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, October 4 to 7, 1994. Washington, DC: American Society for Microbiology, 1994:236.
9. Kennedy D, Geldmacher K, Anderson E. Immunologic response to licensed pneumococcal polysaccharide Vaccine (PS) in infants primed with heptavalent Streptococcus pneumonias conjugated vaccine (CV) [Abstract G90]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, October 4 to 7, 1994. Washington, DC: American Society for Microbiology, 1994:236.
10. Lawrence EM, Edwards KM, Schiffman G, Thompson JM, Vaughn WK, Wright PF. Pneumococcal vaccine in normal children primary and secondary vaccination. Am J Dis Child 1983;137:846-50.
11. Granoff DM, Holmes SJ, Osterholm MT, et al. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J Infect Dis 1993;168: 663-71.
12. 197 conjugate vaccine. J Pediatr 1991;119:655-7.
13. Granoff DM, Weinberg GA, Shackelford PG. IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine. Pediatr Res 1988;24:180-5.
14. Kayhty H, Eskola J, Peltola H, Saarinen L, Makela PH. High antibody responses to booster doses of either Haemophilus influenzas capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines. J Infect Dis 1992:165(Suppl. 1):S165-6.
15. Stevens R, Dichek D, Keld B, Heiner D. IgG1 is the predominant subclass in in vivo- and in vitro-produced anti-tetanus toxoid antibodies and also serves as the membrane IgG molecule for delivering inhibitory signals to anti-tetanus toxoid antibody-producing B cells. J Clin Immunol 1983;3: 65-9.
16. Barrett DJ, Ayoub EM. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol 1986;63: 127-34.
17. Freijd A, Hammarström L, Persson MAA, Smith CIE. Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children. Clin Exp Immuuol 1984; 56:233-8.
18. Siber GR, Schur PH, Aisenberg AC, Weitzman SA, Schiffman G. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med 1980;303:178-82.
19. Bardardottir E, Jonsson S, Jonsdottir I, Sigfusson A, Valdimarsson H. IgG subclass response and opsonization of Streptococcus pneumoniae after vaccination of healthy adults. J Infect Dis 1990;162:482-8.
20. Chudwin DS, Artrip SG, Schiffman G. Immunoglobulin G class and subclass antibodies to pneumococcal capsular polysaccharides. Clin Immunol Immunopathol 1987;44:114-21.
21. Lortan JE, Kaniuk AS, Monteil MA. Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class IgG subclass antibody levels in healthy adults. Clin Exp Immunol 1993;91:54-7.
22. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-6.